US Patent Issued to Zhejiang NanomAb Technology Center on Oct. 14 for "Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolution" (California Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,106, issued on Oct. 14, was assigned to Zhejiang NanomAb Technology Center Co. Ltd. (Shaoxing, China).

"Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolution" was invented by Weimin Zhu (Danville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for generating a plurality of diverse camelid antibodies to cover functional epitopes of the target with high-resolution. Also provided is a method for generating camelid antibodies."

The patent was filed on Aug. 28, 2020, under Application No. 17/434,722.

*For further information, including images, charts and tables, please visit: h...